William J. Ferenczy - 27 May 2022 Form 4 Insider Report for QUIDEL CORP /DE/

Role
SVP, Cardio/Metabolic Unit
Signature
/s/ Phillip S. Askim, attorney-in-fact for William J. Ferenczy
Issuer symbol
N/A
Transactions as of
27 May 2022
Net transactions value
$0
Form type
4
Filing time
01 Jun 2022, 16:21:27 UTC
Previous filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Disposed to Issuer -8,683 -100% 0 27 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -460 -100% $0.000000* 0 27 May 2022 Common Stock 460 $23.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1,349 -100% $0.000000* 0 27 May 2022 Common Stock 1,349 $21.08 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1,727 -100% $0.000000* 0 27 May 2022 Common Stock 1,727 $46.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -3,322 -100% $0.000000* 0 27 May 2022 Common Stock 3,322 $59.12 Direct F2, F4
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -2,609 -100% $0.000000* 0 27 May 2022 Common Stock 2,609 $77.16 Direct F2, F5
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -4,685 -100% $0.000000* 0 27 May 2022 Common Stock 4,685 $103.64 Direct F2, F6
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -1,892 -100% $0.000000* 0 27 May 2022 Common Stock 1,892 $254.00 Direct F2, F7
transaction QDEL Non-Qualified Stock Options Disposed to Issuer $0 -4,957 -100% $0.000000* 0 27 May 2022 Common Stock 4,957 $103.36 Direct F2, F8
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1,661 -100% $0.000000* 0 27 May 2022 Common Stock 1,661 Direct F9, F10, F11
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1,304 -100% $0.000000* 0 27 May 2022 Common Stock 1,304 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -868 -100% $0.000000* 0 27 May 2022 Common Stock 868 Direct F9, F10, F13
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1,420 -100% $0.000000* 0 27 May 2022 Common Stock 1,420 Direct F9, F10, F14
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -4,958 -100% $0.000000* 0 27 May 2022 Common Stock 4,958 Direct F9, F10, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

William J. Ferenczy is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2 Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3 Vested in full.
F4 2,492 shares are vested in full; 830 shares will vest on February 4, 2023.
F5 1,305 shares are vested in full; the remaining 1,304 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F6 2,343 shares are vested in full; the remaining 2,342 shares will vest in equal installments on March 30, 2023 and March 30, 2024.
F7 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F8 1,239 shares will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025; 1,240 shares will vest on January 31, 2026.
F9 Each restricted stock unit represents the right to receive one share of Quidel common stock.
F10 Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F11 1,661 shares will vest on February 4, 2023.
F12 1,304 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F13 868 shares will vest in equal installments on March 30, 2023 and March 30, 2024.
F14 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
F15 1,239 shares will vest on each of January 31, 2023 and January 31, 2024; 1,240 shares will vest on each of January 31, 2025 and January 31, 2026.